跳至主要内容
临床试验/NCT02291276
NCT02291276撤回不适用

Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (GynRight) - Pilot Study

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Venous return

研究概览

简要总结

In this prospective, observational study the investigators assess the perioperative course of right ventricular function in combination with the venous return in patients undergoing major non-cardiac surgery. The study aims to investigate if patients undergoing major non-cardiac surgery develop an impairment of right ventricular function and/or venous return. Furthermore, the study evaluates if an impairment of right ventricular function and/or venous return is associated to left ventricular function, arterial side of the circulation and to postoperative clinical outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Offered patient information and written informed consent
  • Female patients aged greater than or equal to 18 years for cytoreductive surgery of a primary epithelial ovarian tumour
  • Patient Group 1: Female patients with > 500 ml ascites in the preoperative sonographic examination
  • Patient group 2: Female patients aged > 70 years and at least one of the following secondary diagnoses:
  • Status Post stent placement due to coronary heart disease respectively Status Post-myocardial infarction
  • existing arterial Hypertension for more than 5 years
  • chronic heart failure (New York Heart Association (NYHA) class II-III)
  • peripheral arterial disease

排除标准

  • Patients aged less than 18 years
  • Persons without the capacity to consent
  • Inability of German language use
  • Lacking willingness to save and hand out data within the study
  • Accommodation in an institution due to an official or judicial order
  • (Unclear) history of alcohol or substances disabuse
  • Coworker of the Charité
  • Advanced disease of the oesophagus or upper respiratory tract at the beginning of hospitalization
  • Operation in the area of the oesophagus or nasopharynx within the last two months before participation in the study
  • Neurological or psychiatric disease at the beginning of hospitalization
  • CHF (congestive heart failure) according to (New York Heart Association) classification - NYHA class IV at the beginning of hospitalization
  • American Society of Anesthesiologists (ASA) classification greater than IV
  • Renal insufficiency (dependency of haemodialysis) at the beginning of hospitalization
  • Pulmonary oedema in thorax x-ray at the beginning of hospitalization
  • History of intracranial hemorrhage within one year before participation in the study
  • Conditions following venous thrombosis within the last three years before study inclusion
  • Known allergies or hypersensitivity on colloidal, starch or gelatine infusion solutions
  • Diabetes mellitus with signs of severe neuropathy
  • Known atrial fibrillation
  • Participation in an interventional clinical trial during the study period; exception: assignment to adjuvant therapy study during this study is allowed.

结局指标

主要结局

Venous return

时间窗: Up to the first postoperative day

Venous return will be assessed perioperatively by venous return pressure gradient (dVR)

Right ventricular function

时间窗: Up to the first postoperative day

Right ventricular function will be measured perioperatively by a combination of right ventricular stroke volume, tricuspid annular plane systolic excursion (TAPSE), hepatic venous blood flow, variations in diameter of vena cavae, and right ventricle/left ventricle-ratio.

次要结局

  • Venous return variables according to Guyton concept(Up to the first postoperative day)
  • Organ complications(Participants will be followed up until hospital discharge, an average of two weeks)
  • Immunological parameter(Up to the third postoperative day)
  • Endothelial parameter(Up to the third postoperative day)
  • Microvascular function(Up to the first postoperative day)
  • Functional status(Baseline and hospital discharge with an expected average stay of 14 days)
  • Hospital length of stay(Participants will be followed up until hospital discharge, an average of two weeks)
  • Variables of transthoracic and transesophageal echocardiography(Up to the first postoperative day)
  • Postoperative pain(Up to the third postoperative day)
  • Hemodynamic variables(Up to the third postoperative day)
  • Catecholamine administration(Up to the third postoperative day)
  • Blood loss(Up to the third postoperative day)
  • Fluid balance(Up to the third postoperative day)
  • Quality of life(Baseline and hospital discharge with an expected average of 14 days)
  • Intensive care unit length of stay(Participants will be followed up until intensive crae unit discharge, an average of two days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Claudia Spies

Univ.- Prof. Dr. Claudia Spies

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验